Locations
Company type
Result types
Industries
Employees
Founding year
The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Luxembourg Bio Technologies Ltd.
Nes Ziona, Israel
B
11-50 Employees
2008
Key takeaway
The company specializes in peptide synthesis, offering a range of products and innovative coupling reagents that enhance synthesis efficiency and yield. Their commitment to high-quality materials and partnerships with key players in the biotechnology sector underscores their focus on advancing synthetic biology applications.
Reference
Product
PyBOP - Luxembourg Bio Technologies
Request an Information or Quotation Request InformationRequest Information
Almog Diagnostic & Medical Equipment Ltd.
Shoham, Israel
B
11-50 Employees
1988
Key takeaway
Almog is a prominent Life Science company that specializes in providing innovative products and services for research and clinical use, particularly in areas like Molecular Biology and Regenerative Medicine. Their expertise and extensive portfolio may be relevant for those interested in advancements within Synthetic Biology.
Reference
Core business
Home
TargetGene Biotechnologies
Rishon LeZion, Israel
B
1-10 Employees
2012
Key takeaway
TargetGene is focused on developing a leading genome editing platform, which is highly relevant to the field of synthetic biology, particularly in therapeutic applications.
Reference
Core business
TARGETGENE – DEVELOPING THE WORLD’S BEST THERAPEUTIC GENOME EDITING PLATFORM
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
Tarom Applied Technologies
Drom HaSharon Regional Council, Israel
B
11-50 Employees
1989
Key takeaway
The company, SBI - Tarom Applied Technologies, specializes in synthetic biology tools, offering technologies for genome-wide analysis and cellular process regulation, including CRISPR/Cas9 and RNAi libraries. Their focus on innovative molecular technologies supports advancements in diagnostics and therapeutic strategies.
Reference
Product
SBI - Tarom Applied technologies
Tools for the genome-wide analysis of the mechanisms that regulate cellular processes and biological responses Lentiviral Technologies Exosomes Technologies MicroRNA Technologies Stem cell Technologies RNAi Libraries CRISPR/CAS9
Evogene
Rishon LeZion, Israel
B
101-250 Employees
1999
Key takeaway
Evogene is leveraging its CPB platform to advance product pipelines in various fields, including human microbiome-based therapeutics and ag-biologicals, through its subsidiaries. Their focus on utilizing cutting-edge computational biology technologies highlights their commitment to revolutionizing life-science product development.
Reference
Product
Technology – Evogene
Revolutionizing life-science product development utilizing cutting-edge computational biology technologies
LifeGene - People Connecting Science
Kiryat Ono, Israel
B
1-10 Employees
2013
Key takeaway
LifeGene offers the scale-X™ hydro bioreactor, an automated cell culture system specifically designed for the expression and concentration of viral drug substances. Its innovative fixed-bed design enhances upstream processing and scalability, making it ideal for efficient viral production in both development and commercial stages.
Reference
Product
scale-X™ hydro bioreactor - LIFEGENE
scale-X™ hydro bioreactor The scale-X™ hydro bioreactor is a bench-scale automated cell culture system for expression and concentration of viral drug substance, suited for rapid process transfer and development. It features a scalable, fixed-bed bioreactor designed for enhanced upstream processing of viral products. The scale-X hydro controller system enables automated process execution and parameters monitoring and adjustment. With a very low footprint, it is designed to be used in a laminar flow or a biosafety cabinet. scale-X™ bioreactor range Univercells’ scale-X™ bioreactor is a scalable, high-cell-density bioreactor designed to simplify viral production processes thereby enhancing process cost efficiency. The bioreactor design features a fixed bed consisting of alternating sheets of non-woven polyethylene terephthalate (PET) fabric and polyvinyl spacer netting. The unique structure densifies the area available for cell growth in a small volume, which means that much larger number of cells can be grown than in other equipment of a similar footprint. Additional advantages are brought by accurate environmental control (temperature, pH, DO, agitation). The scale-X family is designed to ensure seamless scalability from early process development to commercial manufacturing. The fixed-bed structure provides a high surface area available for cell predictable cell culture in a very low footprint, while delivering similar fluid conditions at all scales, thus ensuring predictable cell & product behavior.
Enzymit
Ness Ziona, Israel
B
1-10 Employees
2020
Key takeaway
Enzymit is revolutionizing bioproduction through its innovative cell-free enzymatic approach, developing custom enzymes that facilitate efficient and environmentally friendly chemical reactions. This advancement positions Enzymit at the forefront of the synthetic biology sector, addressing the need for sustainable manufacturing alternatives.
Reference
Core business
Home | Enzymit | Israel
Enzymit's platform technology can build molecular machines that enable never before seen chemistry aiming to solve humanity's greatest challenges
NewStem
Jerusalem, Israel
B
1-10 Employees
2016
Key takeaway
NewStem is a Bio-Platform company that is pioneering precision medicine therapeutics through the use of Synthetic Lethal interactions with cancer-related mutations. Their innovative approach, centered on haploid human embryonic stem cells (HhESC), lays the foundation for advanced cancer research and the development of solutions for drug resistance.
Reference
Core business
About | NewStem
Bio-Platform company developing medicine therapeutics based on Synthetic Lethal interactions with cancer-related mutations causing genomic instability, and diagnostics for anti-cancer drug resistance.
Hy Laboratories
Rishon LeZion, Israel
B
- Employees
-
Key takeaway
Hy Laboratories Ltd (hylabs) specializes in the development and production of tools for the detection and identification of microorganisms, with a strong focus on molecular biology products. Their expertise in advanced technologies and close collaboration with microbiology specialists position them as key players in the field, which may be relevant to developments in synthetic biology.
Reference
Product
Technology of NGS library preparation - HyLabs
MyBiotics Pharma
Rishon LeZion, Israel
B
11-50 Employees
2014
Key takeaway
MyBiotics is focused on advancing human health through the development of clinically proven probiotics and live biotherapeutic products. Their unique technologies for discovery, delivery, and colonization enhance the efficacy of microbiome treatments, positioning them as innovators in the field of synthetic biology.
Reference
Product
Technology - MyBiotics
Technologies which have been searched by others and may be interesting for you:
The Synthetic Biology industry in Israel is characterized by a vibrant ecosystem, driven by innovation and significant research capabilities. Key considerations include the regulatory environment, which is evolving to address the unique challenges posed by synthetic organisms while promoting safe development and application. Companies must navigate both local and international regulations, including biosafety and biosecurity standards, to ensure compliance and gain market access. The competitive landscape is robust, with numerous startups and established firms pioneering advancements in gene editing, metabolic engineering, and biomanufacturing. Collaboration between academia, industry, and government enhances research and development efforts. Opportunities abound in agriculture, healthcare, and environmental sustainability, particularly in addressing local and global challenges such as food security and disease management. Environmental concerns are pivotal, as synthetic biology can lead to both beneficial and adverse ecological impacts. Companies are encouraged to adopt sustainable practices and conduct thorough environmental risk assessments. Furthermore, the global market relevance of synthetic biology is expanding, with Israel positioned as a key player due to its technological prowess and innovation-driven culture. Engaging with industry networks and attending relevant conferences can provide valuable insights and networking opportunities for those looking to enter this dynamic field.
Some interesting numbers and facts about your company results for Synthetic Biology
| Country with most fitting companies | Israel |
| Amount of fitting manufacturers | 136 |
| Amount of suitable service providers | 54 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 1988 |
| Youngest suiting company | 2020 |
Some interesting questions that has been asked about the results you have just received for Synthetic Biology
What are related technologies to Synthetic Biology?
Based on our calculations related technologies to Synthetic Biology are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Which industries are mostly working on Synthetic Biology?
The most represented industries which are working in Synthetic Biology are Biotechnology, Other, IT, Software and Services, Medical, Pharmaceuticals
How does ensun find these Synthetic Biology Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.